Background-We used intravascular ultrasound (IVUS) to (1) clarify the mechanisms of luminal loss after drug-eluting stent (DES) implantation and (2) classify morphological patterns of in-stent restenosis (ISR). Methods and Results-On the basis of IVUS-identified luminal narrowing (in-stent minimum lumen area Ͻ4 mm 2 ), IVUS-defined ISR was classified as focal (luminal narrowing Յ10 mm in length), multifocal (Ն1 focal lesions), and diffuse (luminal narrowing Ͼ10 mm in length) with or without stent edge involvement. Significant intimal hyperplasia (IH) was defined as IH area Ͼ50% of stent. Overall, 76 lesions had IVUS-defined ISR; 32 (42%) had stent underexpansion (minimal stent area Ͻ5 mm 2 ); and 71 (93%) had IH area Ͼ50% of stent. Total stent length negatively correlated with minimal stent area (rϭϪ0.613, PϽ0.001) as well as with stent area at the minimum lumen site (rϭϪ0.436, PϽ0.001) but not with minimum lumen area (rϭϪ0.084, Pϭ0.472). Underexpansion was present at the minimum lumen site in 15 of 43 (35%) lesions with stent length Ͼ28 mm, even though there was significant IH in 34 (79%) lesions; conversely, in 32 of 33 (97%) lesions with stent length Յ28 mm, the minimum lumen site was not associated with stent underexpansion but significant IH. IVUS-defined focal ISR was most common (47%). Compared with focal ISR, normalized vessel, stent, lumen, and plaque volumes were smaller in diffuse and multifocal than focal ISR, with no difference in IH extent. Conclusions-In most DES restenosis, IH was the dominant mechanism of ISR. Nevertheless, underexpansion associated with longer stent length remained an important preventable mechanism of ISR. (Circ Cardiovasc Interv. 2011;4:9-14.)
D rug-eluting stents (DES) reduce the rate of restenosis and the need for repeat revascularization compared with bare metal stents. [1] [2] [3] Previous studies suggested that rates of in-stent restenosis (ISR) and target lesion revascularization in lesions treated with bare metal stent significantly increased with stent length and the longitudinal extent of luminal narrowing and that the long-term outcome was heavily influenced by the angiographic patterns of the ISR process. 4 Although quantitative coronary angiography has been used to assess late lumen loss, intravascular ultrasound (IVUS) provides more detailed and reliable information on the extent and distribution of intimal tissue, the presence of stent underexpansion, and vascular remodeling. The aims of the current study were to clarify the main mechanisms of ISR, especially at the minimum lumen site.
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Methods
Subjects
Angiographic restenosis was observed in 348 lesions treated with DES implantation between August 2004 and December 2007 from the registry of Asan medical Center, Seoul, Korea. Among them, IVUS images at the time of the first ISR detection were available in 82 patients with 82 lesions (72 patients with repeat revascularization and 10 patients without repeated revascularization). From the same registry data, IVUS data of 312 lesions in 284 patients without angiographic restenosis served as the control group. These studies excluded patients with serious comorbid diseases or terminal illness, graft lesions, hemodynamic instability, ST-elevation myocardial infarction necessitating primary percutaneous intervention, and the inability of the IVUS-imaging catheter to cross lesions into the distal vessels because of severely narrowed lumen. All patients signed written informed consent.
Angiographic Analysis
Qualitative angiographic measurements were done by standard techniques with automated edge-detection algorithms (CASS-5, Pie-Medical, Maastricht, The Netherlands) in the angiographic analysis center of the CardioVascular Research Foundation, Seoul, Korea. [5] [6] [7] [8] Angiographic restenosis was defined as a diameter stenosis Ͼ50% at follow-up angiography and classified as suggested by Mehran et al. 4 
IVUS Imaging and Analysis
IVUS imaging was performed after intracoronary administration of 0.2 mg nitroglycerin using motorized transducer pullback (0.5 mm/s) and a commercial scanner (Boston Scientific/SCIMED, Minneapolis, MN) consisting of a rotating 30-or 40-MHz transducer within a 3.2F imaging sheath. Quantitative volumetric IVUS analysis was performed as previously described. 9, 10 Using computerized plannimetry (Echo-Plaque 3.0, Indec Systems, MountainView, CA), stent and reference segments were assessed every 1 mm. In-stent measurements were also obtained every 1 mm and included external elastic membrane (EEM), stent, lumen (intrastent lumen bounded by the borders of the stent and IH), peristent plaqueϩmedia (PϩMϭEEM minus stent), and intimal hyperplasia (IHϭstent minus intrastent lumen) areas and volumes. Percent IH (%IH) was defined as IH area divided by stent area. All volumes were calculated using the Simpson rule and then normalized for analysis length (normalized volume). Stent underexpansion was defined as minimal stent area (MSA) Ͻ5 mm 2 . 11 Significant IH was defined as %IH area Ͼ50%. Significant luminal narrowing was defined as IVUS-measured lumen area Ͻ4 mm 2 . 12, 13 In the present study, identification of ISR was based on IVUSmeasured significant luminal narrowing; and ISR lesions were classified as follows.
1. Focal ISR was defined as lumen area Ͻ4 mm 2 and Յ10 mm in length confined to the body of stent (focal body type), or extending to the margins of stent (lumen area at the proximal or distal edge Ͻ4.0 mm 2 , focal marginal type).
Multifocal ISR was defined as either multiple focal ISR lesions
confined to the body of the stent (multifocal body type) without involvement of the stent margins or multiple focal ISR lesions that included marginal involvement (multifocal marginal type). 3. Diffuse ISR was defined as lumen area Ͻ4 mm 2 and Ͼ10 mm in length confined to the body of stent (diffuse body type) or extending to the margins of the stent (diffuse marginal type).
The mechanism of ISR was assessed at the minimum lumen site. Dominant stent underexpansion was defined as stent area Ͻ5 mm 2 and IH Ͻ50% at the minimum lumen site. Dominant intimal hyperplasia was defined as stent area Ͼ5 mm 2 and IH Ͼ50% at the minimum lumen site. Mixed underexpansion and intimal hyperplasia was defined as stent area Ͻ5 mm 2 and IH Ͼ50%.
Statistical Analysis
All statistical analyses were conducted using SPSS software (SPSS Inc, Chicago, IL). Categorical data were presented as counts and percentages and compared with 2 statistics or Fisher exact test. Continuous variables were compared by use of the unpaired or paired t test or nonparametric Mann-Whitney test. All IVUS parameters were compared among the 3 groups (focal, multifocal, and diffuse) using ANOVA with post hoc analyses using Bonferroni corrections for multiple comparisons of continuous variables. Receiver-operating curves were analyzed to assess the best cutoff values of total stent length that best separated an MSA Ͻ5 mm 2 from an MSA Ն5 mm 2 with a maximal accuracy, using MedCalc (MedCalc Software, Mariakerke, Belgium). The optimal cutoff was calculated by using Youden index. Pearson correlation coefficient was used to assess the association between parameters. Stepwise multiple regression analysis included the clinical and procedural variables such as age, sex, diabetes, hypercholesterolemia, and total stent length. All predictor variables were subsequently combined in a single regression model to assess their joint effects on the outcome variables by multivariable logistic generalized estimating equations model with robust standard errors that accounted for the clustering between lesions in same patient. The model for each outcome variable was reduced by using backward elimination until it contained only significant predictors. All probability values were 2-sided, and probability values less than 0.05 were considered to indicate statistical significance.
Results
Angiographic ISR Versus Non-ISR Lesions
Baseline clinical and procedural characteristics in 82 lesions with angiographic restenosis (37 sirolimus-eluting stents
[SES], 30 paclitaxel-eluting stents [PES] and 15 zotarolimuseluting stents [ZES]) and 312 lesions without angiographic restenosis are summarized in Table 1 . Multivariable analysis including the clinical and procedural variables identified total stent length (adjusted odds ratio, 1.03; Pϭ0.001; 95% confidence interval, 1.01 to 1.05), diabetes (adjusted odds ratio, 2.08; Pϭ0.012; 95% confidence interval, 1.17 to 3.68), and hypercholesterolemia (adjusted odds ratio, 3.66; PϽ0.001; 95% confidence interval, 2.08 to 6.42) as the independent determinants for the angiographic restenosis. IVUS data at follow-up are summarized in Table 2 .
Of 82 angiographically restenotic lesions, 76 (93%) also fit the definition of IVUS ISR (minimum lumen area [MLA] Ͻ4 mm 2 ) and 32 (39%) had stent underexpansion (MSA Ͻ5 mm 2 ). Conversely, in the 312 lesions without angiographic restenosis, IVUS-measured MLA Ͻ4 mm 2 was found in 83 (27%) lesions; and underexpansion was detected in 75 (24%) lesions. Finally, 6 (7%) of angiographic restenotic lesions had a well-preserved MLA (Ն4 mm 2 ) on IVUS, although 4 of them had restenosis of reference segments.
Mechanisms Contributing to ISR
Among the 76 lesions with both angiographic and IVUS ISR, the minimum lumen site was located at mid portion in 59%, within 5 mm from the proximal stent edge in 22%, and within 5 mm from the distal stent edge in 19%. Overall, 32 (42%) had stent underexpansion (MSA Ͻ5 mm 2 ) and 71 (93%) showed significant IH at some location within the stented segments and not only at the minimum lumen site. However, IVUS analysis at the minimum lumen site showed underexpansion in 16 (21%) lesions, 6 of which were not associated with significant IH (dominant underexpansion). Conversely, 67 (88%) lesions showed significant IH at the minimum lumen site suggesting that IH was the general mechanism of ISR irrespective of the presence of underexpansion (Figure 1 ).
Impact of Stent Length
In the overall cohort of 394 lesions with and without angiographic restenosis, there was a significant relationship between total stent length and MSA (rϭϪ0.365, PϽ0.001). Furthermore, in the 76 lesions with IVUS-defined ISR, total stent length negatively correlated with MSA (rϭϪ0.613, PϽ0.001, Figure 2 ) as well as vessel area (rϭϪ0.416, PϽ0.001), stent area (rϭϪ0.436, PϽ0.001), and %IH area (rϭϪ0.229, Pϭ0.047) at the minimum lumen site but not with the MLA itself (rϭϪ0.084, Pϭ0.472).
On receiver-operating curve analysis, total stent length of 28 mm was the cutoff value that best separated an MSA Ͻ5 mm 2 from an MSA Ն5 mm 2 with 70% sensitivity and 61% specificity. Of 43 ISR lesions with total stent length Ͼ28 mm, 27 (63%) had underexpansion with MSA Ͻ5 mm 2 at some location, compared with only 5 (15%) of 33 ISR lesions with total stent length Յ28 mm (PϽ0.001). At the minimum lumen site, underexpansion was present in 15 (35%) of 43 lesions with total stent length Ͼ28 mm, even though there was significant IH in 34 (79%) lesions. Moreover, underexpansion was the dominant mechanism of ISR in 6 (14%) of them (Figure 3 ). To the contrary, in 32 (97%) of 33 lesions with total stent length Յ28 mm, the MLA was not associated with stent underexpansion but only significant IH (dominant IH, Figure 4 ). In lesions with total stent length Ͼ28 mm, MSA was more frequently located at the distal edge compared with the lesions with total stent length Յ28 mm (49% versus 28%, Pϭ0.044). Total stent length had no relationship with stent area at proximal edge (rϭ0.072, Logistic regression was performed using generalized estimating equations. Pϭ0.537), whereas it negatively correlated with that at distal edge (rϭϪ0.594, PϽ0.001).
In 312 non-ISR lesions on angiography, lesions with total stent length Ͼ28 mm also showed a higher frequency of underexpansion (MSA Ͻ5 mm 2 ) versus lesions with total stent length Յ28 mm: 43 of 121 (36%) versus 32 of 191 (16%), PϽ0.001.
IVUS Patterns of ISR
Using "significant IVUS lumen narrowing" as the criterion for ISR, focal ISR was the most common pattern (47%). The mean lesion length of significant luminal narrowing was 12.7Ϯ10.5 mm in 76 lesions. In 33 lesions with a total stent length Յ28 mm, the lesion length was 7.0Ϯ4.6 mm; and the rates of focal, multifocal, and diffuse ISR were 70%, 15%, and 15%, respectively. In 43 lesions with total stent length Ͼ28 mm, the ISR length was 17.1Ϯ11.6 mm (PϽ0.001 compared with lesions with a total stent length Յ28 mm); the rates of focal, multifocal, and diffuse ISR were 30%, 9%, and 61% (PϽ0.001 compared with lesions with a total stent length Յ28 mm). Comparison of IVUS parameters according to IVUS ISR patterns is shown in Table 3 . Diffuse ISR group showed longer total stent length and higher rate of underexpansion (39%) at the minimum lumen site compared with focal (6%) or multifocal ISR (22%, Pϭ0.004) but a similar rate of significant IH (90% versus 89% and 78%, Pϭ0.581).
Comparing the 3 DES types, there were no differences in the frequencies of angiographic patterns of restenosis (overall Pϭ0.187, Table 4 ) or IVUS patterns of restenosis (overall Pϭ0.545, Table 5 ). With regard to the length of significant IH, Ͼ10 mm in length was observed in SES-treated lesions (9%), PES-treated lesions (32%), and ZES-treated lesions (33%) (Pϭ0.038). PES-treated lesions showed a similar rate of underexpansion (14%) at the minimum lumen site compared with SES-treated lesions (27%) or ZES-treated lesions (20%, Pϭ0.461) but a higher rate of significant IH (100% versus 79% and 87%, Pϭ0.037).
At the minimum lumen site, although there was no significant difference in EEM, stent, lumen, and PϩM area among 3 types of restenotic DES (data not shown), IH area (5.4Ϯ2.3 mm 2 versus 4.1Ϯ1.8 mm 2 , Pϭ0.045), and %IH area (72.4Ϯ11.4% versus 62.5Ϯ15.7%, Pϭ0.026) were greater in PES than SES, with no difference between ZES (5.3Ϯ2.2 mm 2 or 70.4Ϯ15.5%) and SES or PES groups.
Discussion
An IVUS MLA Ͻ4.0 mm 2 is generally accepted to indicate significant luminal narrowing, and that has been used in previous studies as an IVUS definition of ISR. Although underexpansion has been emphasized as the most important mechanism of ISR, most cases of our study had significant IH at the minimum lumen site. Because stents do not chronically recoil, this indicated that IH remained as a general mechanism of luminal loss at the minimum lumen site irrespective of the presence of stent underexpansion. Furthermore, only 16 of 76 ISR lesions had stent underexpansion at the minimum lumen site, with all but 1 in the setting of a total stent length Ͼ28 mm. Conversely, 24% of the lesions without angiographic restenosis showed underexpansion as well.
Because IH was not preventable, interventionists should focus on correction of stent underexpansion during the procedure. A well-expanded stent can provide more room for intimal hyperplasia than an underexpanded stent. IVUS guidance may be helpful to avoid underexpansion especially in long lesions, small vessels, and other stenoses with complex characteristics.
Our data suggest several reasons why total stent length has remained an important predictor for angiographic restenosis even in the DES era. 14, 15 In this current analysis, total stent length significantly correlated with MSA as well as with the stent area at the minimum lumen site; longer stents had smaller in-stent areas and not just at the distal edge in smaller or tapering vessels. We believe that there is a greater possibility for "occult" focal stent underexpansion somewhere within the increased length of longer stents, leading to more severe luminal narrowing irrespective of IH. This may explain the higher restenosis rate in longer stented lesions. The current data indicated that diffuse ISR was associated with smaller stent and vessel areas that was, in turn, associated with a greater frequency of stent underexpansion compared with focal ISR. Our study showed a high frequency of IVUS-defined focal ISR (47%) in DES restenosis. Additionally, Ͼ10 mm of significant IH was less common in SES than PES or ZES. These findings were comparable to previous angiographic data showing that the most common DES restenosis pattern is focal, especially in SES. 16 -19 Furthermore, the magnitude of IH was much greater in PES than in other DES (although the rate of underexpansion was similar), similar to another previous reports. 20 Considering the extent of IH was influenced not by stent length but by DES types, different biological effects in various types of DES may affect the severity of IH.
Limitations
First, this study is retrospective. In 88% of the cases, IVUS was performed during repeated revascularization for the treatment of severe and symptomatic restenotic lesions. Because selection bias might affect the data, our results cannot be extended to the general population with the variable degree of ISR. Second, IVUS data immediately after stenting were not included in this analysis. However, because of the rarity of DES recoil, our interpretation of the relationship between underexpansion and ISR seems reasonable. Third, the cutoff for defining significant luminal narrowing and underexpansion is still a matter of debate, especially in small or very large-sized vessels. Fourth, although stent fracture has been known to play a role in the development of ISR, the implication of DES fracture on the ISR was not evaluated in the current study because of the low incidence of stent fracture. Finally, the current study could not demonstrate any different properties of ISR patterns among 3 DES groups because of small sample size. Class ID confined to body 1 (1%) 1 (3%) 0 (0%) 0 (0%) Class ID involving margins 2 (2%) 1 (3%) 0 (0%) 1 (7%) Class II 20 (24%) 5 (14%) 10 (33%) 5 (33%)
Class III 1 (1%) 1 (3%) 0 (0%) 0 (0%) Class IV 4 (5%) 3 (8%) 1 (3%) 0 (0%) Class I indicates focal (IA, articulation or gap; IB, margin; IC, focal body; ID, multifocal); Class II, diffuse intrastent; Class III, diffuse proliferative; and Class IV, diffuse total occlusion. 
